The worst side effects of immunotherapy happen when the immune system, now supercharged to fight cancer, turns against healthy organs. Heart inflammation, lung inflammation, and severe immune reactions affecting the liver or brain are the most dangerous, with heart-related complications carrying a mortality rate as high as 50%. Most people on immunotherapy experience only mild to moderate side effects, but roughly 50% of patients receiving combination immunotherapy develop severe reactions, making it important to understand what to watch for and when.
Why Immunotherapy Causes Harm to Healthy Tissue
Immunotherapy drugs called checkpoint inhibitors work by releasing the brakes on your immune system. Normally, your body has built-in checkpoints that prevent immune cells from attacking your own tissues. These drugs disable those checkpoints so immune cells can recognize and destroy cancer. The problem is that once those brakes are off, overactivated immune cells can damage organs throughout the body. These reactions are called immune-related adverse events, and they can affect virtually any organ system.
Heart Inflammation
Myocarditis, or inflammation of the heart muscle, is the single most dangerous immunotherapy side effect. It’s rare, occurring in roughly 0.06% to 3.8% of patients, but when it develops, it can be fatal in up to 50% of cases. That mortality rate climbs even higher, to around 66%, in patients receiving two checkpoint inhibitors together compared to 44% with a single drug.
Heart inflammation typically appears early in treatment, with a median onset of about 6 weeks. It progresses rapidly, which makes early detection critical. Symptoms can include chest pain, shortness of breath, irregular heartbeat, fatigue, and swelling in the legs. Because of its speed and severity, most oncology teams monitor heart function closely in the first few months of treatment.
Lung Inflammation
Pneumonitis, or inflammation of the lung tissue, can appear anywhere from one week after starting treatment to six months after the last dose. It shows up on imaging as patterns of lung injury that can affect one lobe or spread across both lungs. In its mildest form, pneumonitis causes no symptoms and is only caught on a scan. In its most severe form, it causes life-threatening breathing failure requiring a ventilator.
The warning signs to know are a new dry cough, shortness of breath (especially with activity that didn’t used to be difficult), chest tightness, or a low-grade fever. Severe pneumonitis, where more than half the lung tissue is affected, requires hospitalization and supplemental oxygen. Catching it early, when it’s still confined to a small area, makes a significant difference in outcomes.
Cytokine Release Syndrome
Some forms of immunotherapy, particularly newer cell-based treatments, can trigger a massive inflammatory response called cytokine release syndrome. This happens when the activated immune system floods the body with signaling molecules all at once. In its mildest form, it looks like a bad flu: fever, headache, muscle aches, fatigue, and nausea. In its most severe form, it causes dangerously low blood pressure and oxygen levels that require intensive care and mechanical ventilation.
The hallmark symptom is a fever of 38°C (100.4°F) or higher. As severity increases, blood pressure drops and breathing becomes harder. Grade 3 and 4 reactions involve organ dysfunction and require aggressive hospital intervention. Fortunately, medical teams treating patients with cell-based immunotherapy expect this reaction and monitor for it in the days following treatment.
Neurological Complications
Immunotherapy can affect the nervous system in ways that range from mild confusion to, in rare cases, coma. Symptoms include headache, difficulty concentrating, slurred speech, trouble writing simple words, seizures, tremors, slower movements, and vision changes. Some patients describe feeling unusually sluggish or sleepy. Severe neurological toxicity that is serious enough to be fatal is uncommon, but it requires immediate attention because symptoms can escalate.
Liver Damage
Liver inflammation typically develops within the first 6 to 12 weeks of treatment. It often causes no obvious symptoms at first, which is why blood tests to check liver function are a routine part of immunotherapy monitoring. When symptoms do appear, they can include yellowing of the skin or eyes, dark urine, nausea, and pain on the right side of the abdomen. Severe liver toxicity can lead to liver failure if not caught and treated promptly.
Permanent Hormonal Changes
Unlike many immunotherapy side effects that resolve once treatment stops, damage to hormone-producing glands is often permanent. Immunotherapy can destroy the thyroid, the pituitary gland, the adrenal glands, or the insulin-producing cells in the pancreas, leaving patients on lifelong hormone replacement.
Thyroid dysfunction is the most common hormonal side effect. Clinical trials reported it in up to 12% of patients, but real-world data shows much higher rates: 8% to 25% of patients on a single checkpoint inhibitor and up to 50% of patients on combination therapy develop thyroid problems. Hypothyroidism (an underactive thyroid) is the most frequent presentation, and most people who develop it will need thyroid medication for the rest of their lives.
Immunotherapy-induced diabetes is rarer, occurring in less than 1% of patients in clinical trials and up to 1.9% in broader studies. Unlike the more common type 2 diabetes, this resembles type 1 diabetes, meaning the immune system has destroyed the cells that make insulin. It requires lifelong insulin treatment. Hormonal side effects tend to appear later than other complications, with a median onset around 14.5 weeks, though they can surface anywhere from 1.5 weeks to over two years into treatment.
Gastrointestinal and Skin Reactions
Colitis (inflammation of the colon) is one of the more common severe side effects, typically appearing about 6 weeks into treatment. Symptoms include diarrhea, abdominal cramping, and sometimes bloody stool. Severe colitis can lead to bowel perforation, which is a surgical emergency. Milder gastrointestinal symptoms like nausea and loose stools are common and not necessarily a sign of serious colitis, but persistent diarrhea, especially more than six times a day, warrants urgent evaluation.
Skin reactions are usually the earliest side effect to appear, with a median onset around 4 weeks. Most are mild, involving rash, itching, or dry skin. Severe skin reactions are less common but can include widespread blistering or peeling that resembles a severe burn. These rare skin reactions require immediate treatment.
Why Combination Therapy Raises the Risk
Patients receiving two checkpoint inhibitors together face substantially higher odds of severe side effects. The rate of grade 3 and 4 reactions (those requiring hospitalization or causing significant organ damage) is approximately 50% with combination therapy. That is noticeably higher than the rates seen with either type of drug used alone. The tradeoff is that combination therapy also tends to produce stronger anti-cancer responses in certain tumor types, which is why oncologists still use it when the potential benefit justifies the increased risk.
When Side Effects Appear
Immunotherapy side effects follow a general pattern. Skin reactions tend to come first, around 4 weeks in. Gastrointestinal and liver problems cluster in the 6 to 12 week range. Heart inflammation peaks around 6 weeks. Hormonal problems develop later, often 3 to 4 months into treatment, though the ranges are wide. Some side effects have appeared more than two years after starting treatment, and lung inflammation can develop up to 6 months after the final dose. This extended timeline means you need to stay alert to new symptoms well beyond the active treatment period.